Bank Hapoalim Bm Edwards Lifesciences Corp Transaction History

Bank Hapoalim Bm

$772 Million
Q1 2024

A detailed history of Bank Hapoalim Bm transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bank Hapoalim Bm holds 31,965 shares of EW stock, worth $2.91 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

31,965

Previous 12,400 157.78%

Holding current value

$2.91 Million

Previous $946,000 222.94%

% of portfolio

0.4%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$72.54 - $95.56 $1.42 Million - $1.87 Million	19,565 Added 157.78%	31,965 $3.06 Million
Q4 2023 Jan 22, 2024	BUY	$61.71 - $77.76 $339,405 - $427,680	5,500 Added 79.71%	12,400 $946,000
Q3 2023 Oct 24, 2023	BUY	$69.28 - $93.38 $48,496 - $65,366	700 Added 11.29%	6,900 $478,000
Q1 2023 Apr 25, 2023	SELL	$74.26 - $84.51 $3,713 - $4,225	-50 Reduced 0.8%	6,200 $513,000
Q4 2022 Jan 26, 2023	SELL	$68.3 - $87.44 $34,150 - $43,720	-500 Reduced 7.41%	6,250 $466,000

Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $24,628 - $32,079	299 Added 4.63%	6,750 $558,000
Q2 2022 Jul 27, 2022	BUY	$86.5 - $128.27 $103,886 - $154,052	1,201 Added 22.88%	6,451 $613,000
Q1 2022 Apr 28, 2022	SELL	$101.96 - $128.34 $205,449 - $258,605	-2,015 Reduced 27.74%	5,250 $618,000
Q4 2021 Feb 04, 2022	SELL	$106.37 - $130.68 $27,656 - $33,976	-260 Reduced 3.46%	7,265 $941,000
Q2 2021 Aug 05, 2021	BUY	$83.84 - $104.76 $33,536 - $41,904	400 Added 5.61%	7,525 $779,000
Q4 2020 Feb 03, 2021	SELL	$71.69 - $91.23 $103,950 - $132,283	-1,450 Reduced 16.91%	7,125 $650,000
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $49,922 - $64,967	-743 Reduced 7.97%	8,575 $684,000
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $356,460 - $476,705	6,195 Added 198.37%	9,318 $644,000
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $3,930 - $6,075	75 Added 2.46%	3,123 $589,000
Q4 2019 Feb 03, 2020	BUY	$71.7 - $82.09 $26,600 - $30,455	371 Added 13.86%	3,048 $711,000
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $12,652 - $14,621	227 Added 9.27%	2,677 $495,000
Q1 2019 May 07, 2019	SELL	$47.89 - $64.05 $48,368 - $64,690	-1,010 Reduced 29.19%	2,450 $469,000
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $21,023 - $25,793	-453 Reduced 11.58%	3,460 $530,000
Q3 2018 Nov 08, 2018	BUY	$45.7 - $58.03 $8,363 - $10,619	183 Added 4.91%	3,913 $681,000
Q2 2018 Jul 24, 2018	BUY	$42.45 - $51.3 $14,857 - $17,955	350 Added 10.36%	3,730 $543,000
Q1 2018 Apr 30, 2018	SELL	$37.19 - $47.45 $170,144 - $217,083	-4,575 Reduced 57.51%	3,380 $472,000
Q4 2017 Feb 05, 2018	BUY	$33.79 - $39.39 $32,100 - $37,420	950 Added 13.56%	7,955 $0
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $254,211 - $272,004	7,005	7,005 $766,000

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Account